Weight‐neutral effect of insulin detemir

By  

JOURNAL OF DIABETES, Vol. 7, Iss. 2, 2015-03 ,pp. : 222-230

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improving glycemic control with insulin detemir using the 303 Algorithm in insulin naïve patients with type 2 diabetes: a subgroup analysis of the US PREDICTIVE 303 study

By Selam Jean-Louis   Koenen Christoph   Weng Wayne   Meneghini Luigi  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 11-20

Informa Healthcare

Access to resources Recommend Favorite

A randomized controlled trial of liraglutide versus insulin detemir plus sitagliptin: Effective switch from intensive insulin therapy to the once‐daily injection in patients with well‐controlled type 2 diabetes

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 831-838

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study

By Wenying Yang   Benroubi Marian   Borzi Vito   Gumprecht Janusz   Kawamori Ryuzo   Shaban Joseph   Shah Siddharth   Shestakova Marina   Ligthelm Robert   Valensi Paul  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2643-2654

Informa Healthcare

Access to resources Recommend Favorite

Treat-to-target comparison between once daily biphasic insulin aspart 30 and insulin glargine in Chinese and Japanese insulin-naïve subjects with type 2 diabetes

By Yang Wenying   Xu Xiangjin   Liu Xiaomin   Yang Gangyi   Seino Yutaka   Andersen Henning   Jinnouchi Hideaki  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1599-1608

Informa Healthcare

Access to resources Recommend Favorite